R. H. A. Becker

New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1

R. H. A. Becker, Raphael Dahmen, Karin Bergmann et al. · Diabetes Care · 2014 · 405 citations

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.

Gabriele Wiemer, Bernward A. Schölkens, R. H. A. Becker et al. · Hypertension · 1991 · 353 citations

Nitric Oxide, Immunology, Cardiovascular Pharmacology +17

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin

Klaus Rave, S. Bott, Lutz Heinemann et al. · Diabetes Care · 2005 · 171 citations · Full text

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia

M. Lorenz, Claudia Pfeiffer, Axel Steinsträßer et al. · Regulatory Peptides · 2013 · 146 citations · Full text

Long-term ACE Inhibition Doubles Lifespan of Hypertensive Rats

Wolfgang Linz, Timm Jessen, R. H. A. Becker et al. · Circulation · 1997 · 124 citations